Disseminating for impact: creating curriculum activities for translational dissemination for the clinical and translational research workforce.

Front Pharmacol

Integrated Translational Health Research Institute of Virginia (iTHRIV), University of Virginia, Charlottesville, VA, United States.

Published: November 2023

There has been an increased focus on the practices associated with dissemination for the translation of research to clinical practice and ultimately, policy. Simultaneously, there has been attention placed on the role of the clinical research workforce in supporting optimal dissemination efforts for impact and societal benefit. Curriculums focused on education opportunities for dissemination for translational scientists have been under-reported. The Translational Science Benefits Model (TSBM) is a framework that has been developed to support assessment of clinical and translational research outcomes that measure impact (both in the clinical and community setting) beyond traditional citations in academic journals/bibliometric activities. The TSBM framework outlines more than 30 different facets of impact and can provide a basis for operationalizing broad impacts of research for translational and clinical scientists. Engagement science offers methods and modalities to work with individual stakeholders, and collaborators in a team science model, and engagement with external scholars and society. This article will describe the use of the TSBM framework and engagement science strategies to develop a translational dissemination framework with novel components for evaluation of dissemination and implementation activities. We propose using the translational dissemination framework to guide the development of an educational curriculum for the clinical research workforce. We outline the educational domains and proposed evaluation criteria essential in implementing this innovative translational dissemination educational content for the clinical and translational research workforce.

Download full-text PDF

Source
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC10663226PMC
http://dx.doi.org/10.3389/fphar.2023.1284662DOI Listing

Publication Analysis

Top Keywords

translational dissemination
16
clinical translational
12
tsbm framework
12
translational
10
dissemination
8
clinical
8
translational workforce
8
clinical workforce
8
engagement science
8
dissemination framework
8

Similar Publications

Are we ready for self-sampling for cervical cancer screening? Insights from service providers and policy makers in Nepal.

PLOS Glob Public Health

January 2025

Britain Nepal Medical Trust, United Kingdom of Great Britain and Northern Ireland (UK), London, United Kingdom.

Cervical cancer is the leading cancer among women in Nepal, but the country has very low screening rate, with only 8.2% of women being screened. In recent years, a self-sampling kit for testing for the human papillomavirus (HPV) has been developed to allow self-sampling and enable early detection of cervical abnormalities.

View Article and Find Full Text PDF

Aims and background This study aims to evaluate Basic Life Support (BLS) knowledge among residents of the Ha'il region. It will reveal the public's familiarity with BLS and identify sources of BLS knowledge. The findings can guide policymakers in improving BLS training, potentially saving lives, especially during cardiac emergencies.

View Article and Find Full Text PDF

Objective: To determine the financial impact of Ehlers-Danlos syndromes (EDS) on patients in the United States by examining the medical expenses incurred by patients.

Patients And Methods: We used a convenience sample approach and disseminated a self-reported survey questionnaire to individuals with EDS via patient advocacy organizations and support groups across the country, social media, and health professionals from April 1, 2023, to December 31, 2023. The survey focused on the out-of-pocket medical expenses incurred by patients.

View Article and Find Full Text PDF

Chromothripsis, a hallmark of cancer, is characterized by extensive and localized DNA rearrangements involving one or a few chromosomes. However, its genome-wide frequency and characteristics in urothelial carcinoma (UC) remain largely unknown. Here, by analyzing single-regional and multi-regional whole-genome sequencing (WGS), we present the chromothripsis blueprint in 488 UC patients.

View Article and Find Full Text PDF

Introduction: Patient and stakeholder involvement enhances the conduct and applicability of comparative effectiveness research (CER). However, examples of engagement practices for CER leveraging real-world data (i.e.

View Article and Find Full Text PDF

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!